Line of Patented Advanced Wound Care Products to be Presented at SAWC Spring
MISSISSAUGA, Ontario–(BUSINESS WIRE)–Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV), an advanced medical technologies company, today announced that two clinical case studies demonstrating the clinical effectiveness of ColActive® Plus and ColActive® Transfer biological matrix products will be presented at the 2018 Symposium on Advanced Wound Care Spring (“SAWC Spring”) in Charlotte, North Carolina. In addition to the posters, Covalon will also be showcasing its full line of advanced wound care dressings in the symposium’s exhibition hall during the three-day event.
“We are very pleased with the results of these two clinical case studies and believe that they show the advantage that the patented ColActive technology can add to a wound care clinician’s arsenal,” said Brian Pedlar, Chief Executive Office of Covalon.
Dr. Jeffrey Lehrman, DPM, FASPS, MAPWCA will present a clinical poster entitled A New Approach in the Management of Chronic Diabetic Foot Ulcers: A Report on the Use of a Collagen Wound Contact Layer with Negative Pressure Wound Therapy during the SAWC Spring – WHS Poster Gala, held on Friday, April 27th from 7:15 p.m. to 8:45 p.m.